Behavioural Science Institute, Radboud University Medical Center, PO Box 9104, 6500, HE, Nijmegen, The Netherlands.
Pro Persona Mental Health Care, Wolfheze 2, 6874 BE, Wolfheze, The Netherlands.
BMC Psychiatry. 2019 Jan 28;19(1):46. doi: 10.1186/s12888-019-2013-y.
Anxiety and depressive disorders are common mental disorders. A substantial part of patients does not achieve symptomatic remission after treatment in specialized services. Current care as usual (CAU) for these patients consists of long-term supportive contacts. Termination of CAU is often not considered to be an option due to persistent symptoms, a low level of functioning, and the absence of further treatment options. A new intervention, ZemCAD, offers a program focused on rehabilitation and self-management, followed by referral back to primary care.
This multicenter randomized controlled trial was carried out in twelve specialized outpatient mental health care services in the Netherlands. Consenting and eligible patients were invited for the MINI interview and the baseline questionnaire. Assessments were done at 6 (T1), 12 (T2) and 18 (T3) months post baseline. We used linear mixed model analysis (LMM) to ascertain the effectiveness of the ZemCAD group relative to the CAU group on quality of life, symptom severity and empowerment.
In total 141 patients were included. The results at 18-month follow-up regarding to quality of life and symptom severity, showed no significant differences between the ZemCAD group and the CAU group, except on the 'social relationships'-domain (d = 0.37). With regard to empowerment a significant difference between both groups was observed in the total empowerment score and one empowerment dimension (d = 0.45 and d = 0.39, respectively). After the ZemCAD intervention, more patients went from specialized outpatient mental health services back to a less specialized health care setting with less intensive treatment, such as primary care.
The findings in this study suggest that patients with chronic and treatment-resistant anxiety and depression using the ZemCAD intervention improve on empowerment but not on symptom severity or quality of life. Since little is known about the effects of rehabilitation and self-management in patients with chronic and treatment resistant anxiety and depressive disorders, this is a first attempt to provide a proof-of-concept study in this under-researched but important field.
Netherlands Trial Register: NTR3335 , registered 7 March 2012.
焦虑和抑郁障碍是常见的精神障碍。相当一部分患者在专科服务机构接受治疗后并未达到症状缓解。目前,对这些患者的常规护理(CAU)包括长期支持性接触。由于持续存在的症状、功能水平低以及缺乏进一步的治疗选择,通常不考虑终止 CAU。一种新的干预措施 ZemCAD 提供了一个专注于康复和自我管理的方案,然后再转介到初级保健。
这项多中心随机对照试验在荷兰的 12 个专门的门诊精神卫生保健服务机构进行。同意并符合条件的患者被邀请进行 MINI 访谈和基线问卷。在基线后 6 个月(T1)、12 个月(T2)和 18 个月(T3)进行评估。我们使用线性混合模型分析(LMM)来确定 ZemCAD 组相对于 CAU 组在生活质量、症状严重程度和赋权方面的有效性。
共纳入 141 名患者。在 18 个月的随访中,关于生活质量和症状严重程度的结果,除了“社会关系”领域(d=0.37)外,ZemCAD 组和 CAU 组之间没有显著差异。在总赋权评分和一个赋权维度方面,两组之间观察到显著差异(d=0.45 和 d=0.39)。在 ZemCAD 干预后,更多的患者从专门的门诊精神卫生服务转回到较少专门化的医疗保健环境,接受较少密集的治疗,如初级保健。
本研究的结果表明,使用 ZemCAD 干预的慢性和治疗抵抗性焦虑和抑郁患者在赋权方面有所改善,但在症状严重程度或生活质量方面没有改善。由于对慢性和治疗抵抗性焦虑和抑郁障碍患者的康复和自我管理的影响知之甚少,因此这是在这个研究不足但重要的领域进行的首次尝试提供概念验证研究。
荷兰试验注册中心:NTR3335,注册日期 2012 年 3 月 7 日。